Cannon Global Investment Management, LLC Eton Pharmaceuticals, Inc. Transaction History
Cannon Global Investment Management, LLC
- $49.7 Million
- Q1 2025
A detailed history of Cannon Global Investment Management, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Cannon Global Investment Management, LLC holds 11,400 shares of ETON stock, worth $190,835. This represents 0.3% of its overall portfolio holdings.
Number of Shares
11,400Holding current value
$190,835% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
74Shares Held
12.9MCall Options Held
284KPut Options Held
4.2K-
Opaleye Management Inc. Boston, MA2.85MShares$47.7 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$30.6 Million1.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.12MShares$18.7 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$17.8 Million0.0% of portfolio
-
Westside Investment Management, Inc.494KShares$8.26 Million1.36% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $423M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...